Moreover, inhibition of FHL2 attenuates cancer cell proliferation and increases E-cad expression in colon cancer cells, suggesting that targeting FHL2 by miR-340-5p might be a useful approach to antagonize colon cancer cell metastasis. Here, FHL2 is linked to malignant colon neoplasm.